Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: San Francisco CA, Oakland CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for
B-cell Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Los Angeles CA, Duarte CA,
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: San Francisco CA, Stanford CA, Santa Barbara CA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: San Francisco CA, Santa Maria CA, Pasadena CA, Vista CA,
Sponsor: Cytokinetics

Sex: All

Age: 40 - 70+

Code: NCT06793371

Phase2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: San Francisco CA, Oakland CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: San Francisco CA, Berkeley CA, Stockton CA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

for
Glioblastoma (GBM)
Location: San Francisco CA, Duarte CA, Newport Beach CA,
Sponsor: Diakonos Oncology Corporation

Sex: All

Age: 18+

Code: NCT06805305

Phase2, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: San Francisco CA, Orange CA, Costa Mesa CA, Irvine CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase2, Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for
Lupus Erythematosus, Systemic
Location: San Francisco CA, Seattle WA, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06897930

Phase1, Phase2, Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: San Francisco CA, Los Angeles CA, San Antonio TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05417594

Phase1, Phase2, Recruiting

Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity

for
Atrial Fibrillation (AF)
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 21+

Code: NCT06995391

Recruiting

Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia

for
Hypoxia
Location: San Francisco CA
Sponsor: Movano Health

Sex: All

Age: 18 - 49

Code: NCT06459206

Recruiting

Pulse Oximeter Accuracy in Healthy Humans During Hypoxia

for
Hypoxia, Skin Pigmentation
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18 - 50

Code: NCT06142019

Recruiting

Dopamine and Sensorimotor Function in Stuttering

for
Stuttering, Adult
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18 - 65

Code: NCT07215884

Phase1, Recruiting
New

Achieving Diagnostic Excellence Through Prevention and Teamwork

for
Diagnostic Errors
Location: San Francisco CA, Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT05747755

Recruiting
New

UCSF Center for Genome Surgery Biobank and Registry

for
Any Conditions That Are Genetic or Suspected to be Genetic in Origin,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 0+

Code: NCT07396285

Recruiting
New

RNA to the RESCUE: Evaluation to Assess the Clinical Utility of RNA Sequencing in Establishing a Genetic Diagnosis or Adjudicating a Previously Established Genetic Diagnosis.

for
Genetic Conditions, Genetic Disorders
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 2+

Code: NCT07787975

Recruiting
New

A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury

for
Acute Kidney Injury
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07734636

Recruiting
New

Assessing Brain Metabolism Using MRS With Deuterated Glucose

for
Glioma
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06594315

Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: Mannkind Corporation

Sex: All

Age: 6 - 17

Code: NCT07224321

Phase2, Recruiting